Clinical Trial Update: Efficacy Study of Botox for Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy of Botox (onabotulinumtoxinA) for major depressive disorder, with the current study status listed as unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Capital Clinical Research Associates, LLC | Conditions: Major Depression | Phase 4 | Status: UNKNOWN